Exelixis | EXEL - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Acadia Pharmaceuticals USD 3.57B 100M 2026-11
Agios Pharmaceuticals USD 1.61B 598M 2026-11
Akebia Therapeutics USD 427M 297M 2025-12
Amgen USD 247.94B 20.06B 2026-11
AstraZeneca USD 213.88B 23.43B 2026-11
Bayer EUR 52.42B 5.31B 2026-11
BioMarin Pharmaceutical USD 10.68B 936M 2026-11
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Cytokinetics USD 7.51B 1.66B 2026-11
Eisai JPY 1.2T 219.32B 2026-06
Eli Lilly USD 1.09T 40.33B 2026-09
Exelixis USD 19.82B 5.34B 2026-11
Genmab DKK 17.1B 88.06B 2026-06
Glaxosmithkline GBP 101.7B 4.58B 2026-11
Incyte USD 24.6B 1.95B 2026-09
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
MacroGenics USD 151M 143M 2026-11
Merck USD 375.59B 17.09B 2026-11
Moderna USD 99.14B 22.26B 2026-11
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 14.46B 45M 2026-11
Novartis USD 292.09B 51.5B 2026-09
Pfizer USD 169.88B 6.47B 2026-11
Sanofi EUR 114.34B 15.65B 2026-11
Takeda JPY 9.26T 1.06T 2026-09
Ultragenyx Pharmaceutical USD 1.37B 108M 2026-11
Xencor USD 2.14B 281M 2026-11